FOXO TECHNOLOGIES INC. Increase (Decrease) in Derivative Liabilities
FOXO TECHNOLOGIES INC. (FOXO) reported Increase (Decrease) in Derivative Liabilities of $28.18 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeLiabilities · last filed 2023-08-10
- FOXO TECHNOLOGIES INC. increase (decrease) in derivative liabilities for the quarter ending 2022-12-31 was $0.00.
- FOXO TECHNOLOGIES INC. increase (decrease) in derivative liabilities for the quarter ending 2022-09-30 was $3.70M.
- FOXO TECHNOLOGIES INC. increase (decrease) in derivative liabilities for the quarter ending 2021-12-31 was -$3.19M.
- FOXO TECHNOLOGIES INC. increase (decrease) in derivative liabilities for fiscal 2022 was $28.18M, a 29.84% increase from fiscal 2021.
- FOXO TECHNOLOGIES INC. increase (decrease) in derivative liabilities for fiscal 2021 was $21.70M.
| Period end | Increase (Decrease) in Derivative Liabilities 3 month | Increase (Decrease) in Derivative Liabilities 6 month | Increase (Decrease) in Derivative Liabilities 9 month | Increase (Decrease) in Derivative Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.70M derived: sum of 2 quarters · filed 2023-03-31 | $28.18M 10-K · filed 2023-03-31 | |
| 2022-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $28.18M 10-Q · filed 2022-11-21 | ||
| 2022-06-30 | $24.48M 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | -$3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $21.70M 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $24.89M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |